UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 (615) 344-9551 (Registrant's telephone number, including area code) Not Applicable (Former name, former address and former fi ...

Group 1 - The article discusses the uncertainty faced by investors during the onset of COVID-19, highlighting the dilemma of whether to sell stocks amid falling prices or to buy in anticipation of a recovery if the virus is contained [1] - It mentions a long/short partnership strategy as a potential approach for investors with 25 years of experience in business and finance [1] Group 2 - The article does not provide specific company or industry insights, focusing instead on general investment strategies and the author's background [2][3]

Core Insights - HCA Healthcare, Inc. reported second-quarter 2025 adjusted earnings per share (EPS) of $6.84, exceeding the Zacks Consensus Estimate by 10.5% and showing a year-over-year improvement of 24.4% [1][9] - Revenues reached $18.6 billion, reflecting a 6.4% year-over-year increase and surpassing the consensus mark by 0.7% [1][9] Financial Performance - The quarterly results were supported by increased patient volumes, higher same-facility revenue per equivalent admission, and a rise in emergency room visits [2] - Same-facility equivalent admissions grew by 1.7% year over year, while same-facility admissions increased by 1.8%, both below growth estimates of 3.8% and 4% respectively [3] - Same-facility revenue per equivalent admission rose by 4% year over year, exceeding the growth estimate of 3.2% [3] - Adjusted EBITDA improved by 8.4% year over year to $3.8 billion, beating the estimate of $3.6 billion [5] Cost and Expenses - Salaries and benefits, supplies, and other operating expenses totaled $14.78 billion, increasing by 6% year over year but lower than the estimate of $14.84 billion [4] - Same-facility inpatient surgeries decreased by 0.3% year over year, missing the growth estimate of 1.5%, while same-facility outpatient surgeries fell by 0.6% [4] Cash Flow and Capital Management - HCA generated $5.9 billion in cash from operations in the first half of 2025, a 32% increase from the prior-year period [8] - The company repurchased $2.5 billion in shares during the quarter and had a remaining capacity of $5.8 billion under its buyback authorization [10] Guidance and Outlook - HCA revised its 2025 revenue guidance to between $74 billion and $76 billion, up from the previous range of $72.8 billion to $75.8 billion, indicating a 6.2% rise from 2024 [11] - Adjusted EBITDA is now expected to be in the range of $14.7 billion to $15.3 billion, higher than the earlier forecast [12] - EPS is projected to be in the $25.5 to $27 range for 2025, an increase from the previous estimate [13]

Financial Data and Key Metrics Changes - The company reported a 24% increase in diluted earnings per share, adjusted to $6.84, reflecting strong financial results for the second quarter [6] - Revenue growth was 6.4%, driven by increased demand for services, improved payer mix, and stable patient acuity levels [6][13] - Adjusted EBITDA margin improved by 30 basis points compared to the prior year quarter, with adjusted EBITDA growing 8.4% year-over-year [13][14] Business Line Data and Key Metrics Changes - Equivalent admissions increased by 1.7% for the quarter and 2.3% year-to-date, with managed care equivalent admissions growing by 4% [12] - Medicare admissions grew by 3%, slightly below expectations, while Medicaid saw a slight decline and self-pay increased slightly [12][13] - The company experienced a $100 million increase in net benefit from Medicaid supplemental payment programs compared to the prior year quarter [14] Market Data and Key Metrics Changes - Approximately 60% of the company's Medicaid volumes and revenue are in non-expansion states, which mitigates the expected impact of recent federal policy changes [9] - The company anticipates some individuals will lose insurance coverage due to changes in federal policies, but believes its financial resiliency program will offset these effects [10][11] Company Strategy and Development Direction - The company aims to combine high-quality local health networks with national capabilities to reinforce its competitive position and respond to market dynamics [8] - A balanced capital allocation strategy is in place, with $1.2 billion in capital expenditures, $2.5 billion in share repurchases, and $171 million in dividends planned for 2025 [15][19] - The company is optimistic about future growth, with a diversified portfolio of markets and ongoing investments in outpatient facilities and inpatient capacity [20][57] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to manage the impacts of federal policy changes and maintain a strong balance sheet [11] - The company has seen a recovery in facilities affected by Hurricane Saline and Milton, with better-than-expected performance in some markets [21] - Management noted that 14 out of 15 divisions grew their admissions, indicating strong underlying business performance despite some volume metrics being lower than expected [33][34] Other Important Information - The company is actively developing resiliency programs to mitigate potential adverse impacts from federal policy changes and is focused on operational improvements [40] - The company has approximately $5.5 billion in capital projects underway, which are expected to enhance its network and service capacity [57][108] Q&A Session Summary Question: Guidance update and impact of Tennessee DPP program - Management confirmed that the updated guidance reflects the approval of the Tennessee DPP program and better visibility on other programs [27][28] Question: Resiliency programs and potential headwinds - Management indicated that their financial resiliency program should offset adverse impacts from federal policy changes, with further details to be provided in the fourth quarter earnings call [39][40] Question: Commercial volume trends and consumer confidence - Management noted that managed care equivalent admissions are up 4% year-to-date, with health care exchanges performing better than expected [45][46] Question: Market share dynamics and local market performance - Management reported sustained market share gains, with a focus on improving network integrity and patient retention [56][57] Question: Changes in Medicare Advantage behavior and revenue cycle investments - Management stated that there have been no significant impacts from denial activities, reflecting improvements in revenue cycle management [67][68] Question: Update on commercial contracting and capital expenditures - Management confirmed that they are largely contracted for 2025 and about 80% contracted for 2026, with ongoing capital investments to enhance service capacity [106][108]

HCA Healthcare (HCA) Q2 2025 Earnings Call July 25, 2025 10:00 AM ET Speaker0Ladies and gentlemen, welcome to HCA Healthcare's Second Quarter twenty twenty five Earnings Conference Call. Today's call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations, Mr. Frank Morgan. Please go ahead, sir.Speaker1Good morning, and welcome to everyone on today's call. With me this morning is our CEO, Sam Hazen and our CFO, Mike M ...

HCA Healthcare (HCA) came out with quarterly earnings of $6.84 per share, beating the Zacks Consensus Estimate of $6.19 per share. This compares to earnings of $5.5 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +10.50%. A quarter ago, it was expected that this hospital operator would post earnings of $5.77 per share when it actually produced earnings of $6.45, delivering a surprise of +11.79%.Over the last four quarters, the ...

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE REPORTS SECOND QUARTER 2025 RESULTS RAISES 2025 GUIDANCE Nashville, Tenn., July 25, 2025 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2025. Key second quarter metrics (all percentage changes compare 2Q 2025 to 2Q 2024 unless otherwise noted): "We are pleased to report strong financial results for ...

HCA Healthcare, Inc. HCA will release earnings results for the second quarter before the opening bell on Friday, July 25.Analysts expect the Nashville, Tennessee-based company to report quarterly earnings at $6.32 per share, up from $5.5 per share in the year-ago period. HCA Healthcare is projected to report quarterly revenue of $18.5 billion, compared to $17.49 billion a year earlier, according to data from Benzinga Pro.On July 11, HCA Healthcare named John W. Chidsey, III as a new Independent Director.HCA ...

Wall Street analysts forecast that HCA Healthcare (HCA) will report quarterly earnings of $6.14 per share in its upcoming release, pointing to a year-over-year increase of 11.6%. It is anticipated that revenues will amount to $18.46 billion, exhibiting an increase of 5.5% compared to the year-ago quarter.The current level reflects a downward revision of 0.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraise ...

Core Insights - HCA Healthcare, Inc. is expected to report second-quarter 2025 results on July 25, with earnings estimated at $6.14 per share and revenues at $18.46 billion [1] - The earnings estimate reflects an 11.6% increase year-over-year, while revenue is projected to grow by 5.5% [2] - For the full year 2025, revenue is estimated at $74.6 billion, indicating a 5.7% year-over-year rise, and EPS is projected at $25.26, a 15% increase [3] Earnings Performance - HCA has a history of exceeding earnings estimates, achieving this in the last four quarters with an average surprise of 7.1% [3] - However, current indicators suggest uncertainty regarding an earnings beat for the upcoming quarter, with an Earnings ESP of -8.77% and a Zacks Rank of 3 [4] Operational Metrics - The consensus estimate for equivalent admissions indicates a 2.9% year-over-year growth, with revenue per equivalent admission also expected to rise by 2.9% [5] - Equivalent patient days are projected to grow by 4.3% year-over-year, and occupancy is expected to increase to 73.1% from 71.9% a year ago [5] Cost and Surgery Trends - Total operating expenses are anticipated to rise by 6.5% year-over-year, driven by higher salaries, benefits, and supply costs, with supply costs expected to increase by 5.3% [8] - A decline of 2.2% in outpatient surgery cases is projected, along with a 1.4% decrease in the average length of stay [9]